XFOR
X4 Pharmaceuticals, Inc
NASDAQ · Healthcare · Biotechnology · US
$3.58
+2.29%Aug 6, 2026, 20:15 UTC
X4 Pharmaceuticals reported financial results for the second quarter ended June 30, 2026.
Source:Jul 1, 2026, 11:00 UTC
X4 Pharmaceuticals appointed Kelly Gold to its Board of Directors as an independent director and member of the Audit Committee, effective July 1, 2026.
Source: